DK1492796T3 - Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler - Google Patents

Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler

Info

Publication number
DK1492796T3
DK1492796T3 DK03714897T DK03714897T DK1492796T3 DK 1492796 T3 DK1492796 T3 DK 1492796T3 DK 03714897 T DK03714897 T DK 03714897T DK 03714897 T DK03714897 T DK 03714897T DK 1492796 T3 DK1492796 T3 DK 1492796T3
Authority
DK
Denmark
Prior art keywords
aminoisoxazoline
antidepressants
derivatives
substituted
substituted aminoisoxazoline
Prior art date
Application number
DK03714897T
Other languages
English (en)
Inventor
Margaretha Henrica Mari Bakker
Jose Igancio Andres-Gil
Manuel Jes Alcazar-Vaca
Lucas Olivares Ana Isabel De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1492796T3 publication Critical patent/DK1492796T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK03714897T 2002-04-02 2003-03-27 Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler DK1492796T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076239 2002-04-02
PCT/EP2003/003245 WO2003082878A1 (en) 2002-04-02 2003-03-27 Substituted amino isoxazoline derivatives and their use as anti-depressants.

Publications (1)

Publication Number Publication Date
DK1492796T3 true DK1492796T3 (da) 2007-12-03

Family

ID=28459528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03714897T DK1492796T3 (da) 2002-04-02 2003-03-27 Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler

Country Status (24)

Country Link
US (1) US7265103B2 (da)
EP (1) EP1492796B1 (da)
JP (1) JP4580653B2 (da)
KR (1) KR20040093061A (da)
CN (1) CN100349897C (da)
AR (1) AR039207A1 (da)
AT (1) ATE372342T1 (da)
BR (1) BR0308309A (da)
CA (1) CA2480113C (da)
DE (1) DE60316134T2 (da)
DK (1) DK1492796T3 (da)
EA (1) EA008189B1 (da)
ES (1) ES2292949T3 (da)
HK (1) HK1080072A1 (da)
HR (1) HRP20040871A2 (da)
IL (2) IL164341A0 (da)
MX (1) MXPA04008626A (da)
NO (1) NO20044645L (da)
NZ (1) NZ536109A (da)
PL (1) PL211708B1 (da)
PT (1) PT1492796E (da)
TW (1) TWI286138B (da)
WO (1) WO2003082878A1 (da)
ZA (1) ZA200407904B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
US7462717B2 (en) * 2002-08-21 2008-12-09 Janssen Pharmaceutica N.V. C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants
US7635696B2 (en) 2004-11-26 2009-12-22 Janssen Pharmaceutica N.V. Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
KR101150628B1 (ko) * 2007-07-03 2012-05-31 에프. 호프만-라 로슈 아게 4-이미다졸린 및 항우울제로서 이의 용도
WO2010104194A1 (en) 2009-03-10 2010-09-16 Takeda Pharmaceutical Company Limited Benzofuran derivatives
US20130062732A1 (en) 2011-09-08 2013-03-14 International Business Machines Corporation Interconnect structures with functional components and methods for fabrication
CN105801510A (zh) * 2016-04-08 2016-07-27 李勇 一种治疗抑郁症的药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68906340T2 (de) 1988-09-19 1993-08-12 Akzo Nv Tetrahydronaphthalin und indan-derivate.
HUP9903706A3 (en) 1996-01-05 2000-09-28 Hoechst Marion Roussel Inc Cin 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity, process for their preparation and pharmaceutical compositions containing the same
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
ATE337322T1 (de) * 2001-02-21 2006-09-15 Janssen Pharmaceutica Nv Isoxazolin-derivate als antidepressiva
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
US7462717B2 (en) * 2002-08-21 2008-12-09 Janssen Pharmaceutica N.V. C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants

Also Published As

Publication number Publication date
TWI286138B (en) 2007-09-01
IL164341A0 (en) 2005-12-18
HK1080072A1 (zh) 2006-04-21
EA008189B1 (ru) 2007-04-27
EP1492796B1 (en) 2007-09-05
ES2292949T3 (es) 2008-03-16
PL211708B1 (pl) 2012-06-29
ATE372342T1 (de) 2007-09-15
DE60316134T2 (de) 2008-05-29
MXPA04008626A (es) 2004-12-06
NO20044645L (no) 2004-10-27
CA2480113A1 (en) 2003-10-09
US20050222125A1 (en) 2005-10-06
PL371630A1 (en) 2005-06-27
EP1492796A1 (en) 2005-01-05
US7265103B2 (en) 2007-09-04
NZ536109A (en) 2006-06-30
IL164341A (en) 2009-06-15
KR20040093061A (ko) 2004-11-04
JP2005522469A (ja) 2005-07-28
AR039207A1 (es) 2005-02-09
WO2003082878A1 (en) 2003-10-09
HRP20040871A2 (en) 2005-04-30
DE60316134D1 (de) 2007-10-18
JP4580653B2 (ja) 2010-11-17
ZA200407904B (en) 2005-10-20
EA200401297A1 (ru) 2005-02-24
CN1642960A (zh) 2005-07-20
BR0308309A (pt) 2004-12-28
CA2480113C (en) 2012-04-24
PT1492796E (pt) 2007-11-16
TW200406414A (en) 2004-05-01
AU2003219111A1 (en) 2003-10-13
CN100349897C (zh) 2007-11-21

Similar Documents

Publication Publication Date Title
DK1478629T3 (da) N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
DK1480955T3 (da) O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
DK1660491T3 (da) Benzimidazol-, benzthiazol- og benzoxazolderivater og deres anvendelse som LTA4Hmodulatorer
DK1539712T3 (da) Pyrimidinderivater og deres anvendelse som CB2-modulatorer
NO20053356L (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
DK1789401T3 (da) Isoxazolinderivater og deres anvendelse som herbicider
NO20044137L (no) Aminoindazolderivater, deres fremstilling og anvendelse samt mellomprodukter
DK2305250T3 (da) Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer
NO20053215D0 (no) Pyrazolderivater med anvendelse som COX-1-inhibitorer.
NO20050426L (no) Arylkarbonylderivater som terapeutiske midler
DK1594867T3 (da) Phenylacetamider og deres anvendelse som glucokinasemodulatorer
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
DK1501815T3 (da) Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer
DK1723128T3 (da) Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
DK1558615T3 (da) Purin-forbindelser og deres anvendelse som cannabinoid receptor ligander
DK1480962T3 (da) 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer
DK1246802T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
DK1500654T3 (da) Benzoxazinonderivater, fremstilling deraf og anvendelse deraf som lægemidler
NO20052995D0 (no) 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer.
NO20050665L (no) Pyrrolidonderivater som MAOE inhibitoere
DK1670458T3 (da) 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika
DK1581518T3 (da) Substituerede 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazin-derivater og deres anvendelse som neurokinin antagonister
DK1636228T3 (da) Nye pyridopyraziner og deres anvendelse som kinasemodulatorer
NO20043580D0 (no) Quinazolinonderivater og deres bruk som CB agonister
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler